Nyra Medical

medical devices

About

Nyra Medical is a clinical-stage medical device company based in Georgia, USA, founded in 2019. The company focuses on advancing transcatheter repair for functional mitral regurgitation (FMR) through its core product, the Cardiac Leaflet Enhancer (CARLEN) System. This innovative, image-guided, catheter-based intervention aims to treat FMR by augmenting the mitral valve leaflet, enhancing valve function, and expanding treatment options for patients. The CARLEN System is designed to improve leaflet coaptation and valve competence, making it suitable for patients who may not qualify for traditional repair methods. Nyra Medical's leadership team, which includes experienced professionals in regulatory strategy and clinical research, is dedicated to progressing CARLEN through clinical trials and regulatory approvals. The company is committed to expanding access to effective mitral valve repair therapies and addressing unmet needs in the treatment of FMR.

Technologies

WordPress.org Google Tag Manager Mobile Friendly Remote Android Circle Data Analytics Seismic AI Render

Keywords

cardiovascular devices interventional cardiology tmvr ttvr tricuspid valve medtech mitral valve future intervention options carlen technology b2b single-leaflet device valvular heart disease fmr treatment carlen system anatomical versatility physiological flow preservation native leaflet augmentation single-leaflet mitral device structural heart care medical devices future transcatheter interventions transcatheter mitral valve repair transcatheter device global clinical research mitral regurgitation healthcare technology transfemoral delivery mitral valve repair mitral valve anatomy services

Location

Atlanta, Georgia, United States

Related Companies

Companies in the same industry